Trybe Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.08M |
| 2 |
ServiceNow
NOW
|
+$2.55M |
| 3 |
Ginkgo Bioworks
DNA
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$5.72M |
| 2 |
Apple
AAPL
|
+$4.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.71% |
| 2 | Communication Services | 10.29% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Healthcare | 0.77% |
Similar funds
Trybe Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Trybe Capital Management held 13 positions worth $183M, up 76% from $104M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Trybe Capital Management deployed $32.7M of net new capital in Q1 2023, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was Ginkgo Bioworks: 26,359 shares worth $1.4M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 59% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $4.19M trimmed.
- Trybe Capital Management's largest Q1 2023 buy was Ginkgo Bioworks: 26,359 shares worth $1.4M.
- Trybe Capital Management added most to Amazon in Q1 2023, an estimated $4.08M increase.
- Trybe Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $4.19M.
- Trybe Capital Management fully exited Marvell Technology in Q1 2023, selling an estimated $5.72M.
- Trybe Capital Management's ten largest holdings make up 96% of its $183M portfolio in Q1 2023.
- Trybe Capital Management opened 3 new positions and closed 1 in Q1 2023.
- Trybe Capital Management's portfolio value rose 76% quarter-over-quarter to $183M.
Based on Trybe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.